Posts by: Patricia Inacio, PhD

News

A new imaging agent for use in positron emission tomography (PET) is better than conventional imaging at detecting cancer location and spread in prostate cancer patients suspected of cancer ... Read more

September 5, 2018

Higher Radiotherapy Doses But Fewer Treatment Sessions May Be Possible, Early Trial Data Suggest

News

Prostate cancer patients may benefit from a new form of radiation therapy that delivers larger doses per session but in a much shorter treatment course, and when used in ... Read more

August 8, 2018

Simple Blood Test Could Determine Best Treatment Option for Advanced Prostate Cancer, Study Says

News

A blood test that examines circulating tumor cells for the presence of the AR-V7 protein could help determine if a patient with advanced prostate cancer would fare better with ... Read more

June 4, 2018

Laser-guided Treatment Better in Long Term than Monitoring for Low-risk Prostate Cancer, New Phase 3 Data Show

News

Prostate cancer patients who undergo a nonsurgical procedure to remove part of their prostate gland — using a kind of photodynamic therapy targeting the blood vessels — fare better ... Read more

May 7, 2018

Exposure to Blue Light at Night May Increase Risk of Prostate, Breast Cancer, Study Says

News

Exposure to artificial light at night, such as the blue light emitted by most LEDs and computer and smartphone screens, may increase the risk of developing prostate cancer and ... Read more

May 3, 2018

New Ultrasound Imaging Technique Detects Prostate Cancer with More Accuracy, Study Says

News

A variation of ultrasound imaging, called shear wave elastography (SWE), may help detect signs of prostate cancer with higher accuracy and reliability than current methods, according to new research. ... Read more

April 9, 2018April 9, 2018

Focal Ultrasound Prostate Ablation Shows Promising Results with Fewer Side Effects

News

A procedure that eliminates only the diseased part of the prostate in prostate cancer patients has shown promising results while causing fewer side effects, including incontinence and impotence, compared to ... Read more

February 16, 2018February 16, 2018

First Therapy for Non-metastatic, Castration-resistant Prostate Cancer Patients Approved in US

News

The U.S. Food and Drug Administration (FDA) approved Johnson & Johnson’s Erleada (apalutamide), a next-generation androgen receptor inhibitor, as therapy for patients with localized (non-metastatic) prostate cancer who failed to ... Read more

February 2, 2018

New Compounds May Counteract Chemotherapy Resistance in Prostate Cancer Cells

News

Researchers at Southern Methodist University discovered three new small molecules that overcome the resistance to chemotherapy observed in patients with prostate, breast, and ovarian cancer. The study, “Targeted inhibitors of ... Read more

January 22, 2018

High-fat Diets May Promote Prostate Cancer Metastasis, Mouse Study Suggests

News

Loss of two tumor suppressor genes – PTEN and PML – in prostate cancer appears to trigger the progression of disease by turning the cells into fat-producing factories, new ... Read more